Document Type
Article
Publication Date
10-8-2024
Abstract
"In December 2023, JACCP published a content analysis of state legislative bills focused on expanding pharmacist scope of practice to provide human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP).1 All states permit pharmacists to prescribe under a collaborative practice agreement with approximately half of the states granting HIV PrEP and post-exposure prophylaxis (PEP) authority to prescribe either via legislation, standing orders, or statewide protocols.2-4 New York was the first state to expand pharmacists' specific authority for HIV prevention in 2017; however, California was the first state to pass legislation with Senate Bill 159 (SB 159) in 2019 using the term “furnishing” instead of prescribing.5 Fast forward to 2024, and California passed a new Senate Bill (SB 339) expanding pharmacist-prescribed HIV PrEP and PEP. While California was one of the early pioneers in codifying the importance of the pharmacist's role in HIV prevention, there are also many lessons to be learned from this tale of two bills that other states should consider as they attempt to expand the pharmacist's HIV prevention efforts."
Recommended Citation
Cocohoba, J., Lam, J., Lopez, M. and Dong, B.J. (2024), A tale of two bills: Lessons learned in expanding pharmacist-led HIV pre-exposure and post-exposure prophylaxis. J Am Coll Clin Pharm, 7: 982-983. https://doi.org/10.1002/jac5.2027
Copyright
Pharmacotherapy Publications, Inc.
Included in
Health Law and Policy Commons, Immune System Diseases Commons, Pharmacy Administration, Policy and Regulation Commons, Virus Diseases Commons
Comments
This is the accepted version of the following article:
Cocohoba, J., Lam, J., Lopez, M. and Dong, B.J. (2024), A tale of two bills: Lessons learned in expanding pharmacist-led HIV pre-exposure and post-exposure prophylaxis. J Am Coll Clin Pharm, 7: 982-983. https://doi.org/10.1002/jac5.2027
which has been published in final form at https://doi.org/10.1002/jac5.2027. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.